Position in ZTS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$699,557
+$65,715 QoQ
Shares Held
9,735
+81.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#723
of 1,413 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vise Technologies, Inc. holds $11,149,412 across 18 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
118,124 | $1,893,527 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
39,384 | $1,334,329 | |
| 3 | VTRS |
Viatris Inc
|
59,464 | $944,288 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,659 | $898,895 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
23,386 | $810,792 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
48,504 | $702,822 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
9,735 | $699,557 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
3,360 | $566,294 |
All Filings in ZTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,557 | 9,735 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $633,842 | 5,362 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $674,646 | 5,362 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,033,019 | 7,060 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,802,002 | 11,555 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $912,733 | 5,602 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $666,831 | 3,413 | Shares | Sole | 2024-11-13 | |
| 2022-03-31 | $217,821 | 1,155 | Shares | Sole | 2022-06-08 | |
| 2021-12-31 | $527,104 | 2,160 | Shares | Sole | 2022-06-07 | |
| No filing history on record for this holder in this stock. | ||||||